AKEEGA®—the only FDA-approved treatment option combining two drugs into one tablet for adults with BRCA+ metastatic castration-resistant prostate cancer (mCRPC)

Living with advanced prostate cancer can be challenging; ask your doctor how AKEEGA®, a once-daily treatment option, may help.

Person with Green Background Mobile

Not an actual patient

Janssen Oncology

Janssen has built a legacy of innovation in the treatment of prostate cancer with the goal of extending life and helping patients enjoy the highest possible quality of life.

Four Person Group Image DesktopFour Person Group Image Mobile

Stay up-to-date About AKEEGA®

Janssen Biotech, Inc., our affiliates, and our service providers will use the information you provide to send you information about AKEEGA® or BRCA+ mCRPC and for any optional requests you may select. Please note that the subject line of emails you receive may include the AKEEGA® name. You may unsubscribe by following the instructions near the end of each message. Our Privacy Policy further governs the use of the information you provide.

Select one